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Abstract
In this chapter, we deal with the current knowledge and important results on the cyto‐
skeletal proteins and their differential regulation by kinases/phosphatases and Ca2+‐
mediated mechanisms in developmental rat brain. We focus on the misregulation of the 
phosphorylating system associated with intermediate filament proteins of neural cells 
and its relevance to cell and tissue dysfunction. Taking into account our findings, we 
propose that intermediate‐filament proteins are dynamic structures whose regulation is 
crucial for proper neural cell function. Given their relevance, they must be regulated 
in response to extracellular and intracellular signals. The complexity and connection 
between signaling pathways regulating intermediate‐filament dynamics remain obscure. 
In this chapter, we get light into some kinase/phosphatase cascades downstream of 
membrane receptors disrupting the dynamics of intermediate filaments and its associa‐
tion with neural dysfunction. However, intermediate filaments do not act individually 
into the neural cells. Our results evidence the importance of misregulated cytoskeletal 
crosstalk in disrupting cytoskeletal dynamics and cell morphology underlying neural 
dysfunction in experimental conditions mimicking metabolic diseases and nongenomic 
actions of thyroid hormones and as an end point in the neurotoxicity of organic tellurium.
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1. Introduction
All the cell functions accomplished by the living cell are dependent on a sophisticated net‐
work of protein filaments with different compositions, distributions and roles into the cell, 
forming an integrated meshwork known as the cytoskeleton. However, the most striking fea‐
ture of the cytoskeleton concerns its ability to respond to signals and conditions to which cells 
are submitted, taking part of adaptive cell response to different stimuli. The cytoskeleton is 
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an end point of signaling pathways adapting cells to immediate or long‐lasting behaviors in 
healthy and sick organisms.
Cytoskeleton of most animal cells is constituted by three interconnected filament subsystems: 
microfilaments (MFs), microtubules (MTs) and intermediate filaments (IFs). Compelling 
evidence from the last decades has brought convincing understanding for the highly regu‐
lated and interconnected interactions between the cytoskeletal elements giving support to 
sculpting and maintaining cell shape and sustaining all kinds of morphological alterations or 
internal organization, as well as their implications for the behavior of animal cells. Figure 1 
demonstrates the organization of the cytoskeleton in neurons.
A cohort of accessory proteins and signaling machinery regulates the dynamic turnover of the 
cytoskeleton. Although each type of filament has specific cell distribution, molecular constitu‐
ents and equilibrium, the coordinated intertwining among the different networks provides 
the force for a number of coherent processes in response to all kinds of intra‐ and extracellular 
stimuli leading responses so decisive as cell survival or death [1].
This chapter initiates with a brief introduction about the structure and function of IFs, empha‐
sizing those from neural cells. However, the main purposes of the chapter are the experimen‐
tal evidence of our laboratory that the roles of IFs are beyond protection from mechanical and 
nonmechanical stress. They might be the end point of misregulated‐signaling mechanisms in 
neurotoxic conditions adapting their dynamics, in concert with the other cytoskeletal fibers, 
to cell survival or death.
Figure 1. Distribution of cytoskeletal constituents into neurons. Neuronal cytoskeleton is composed by microfilaments, 
microtubules, and intermediate filaments. The microtubules are nucleated at the centrosome, then released and delivered 
to either the dendrites or the axon. Neurofilaments are abundant in axons and the spacing of neurofilaments is sensitive 
to the level of phosphorylation. The microfilaments are dispersed within the cells and they are most abundant near the 
plasma membrane.
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2. Intermediate filaments
2.1. Molecular architecture of intermediate filaments
IFs are flexible, rod‐shaped fibers averaging 10 nm in diameter, a size that is intermediate 
between MFs and MTs. They are ubiquitous constituents of the structural scaffold of the 
eukaryotic cells and considered mechanical integrators of cytomatrix [2]. These cytoskeletal 
filaments are widespread expressed in practically all animal cell types and are the most diverse 
cytoskeletal protein family, encoded by an estimated 70 IF genes in the humans. IFs have 
been grouped into six sequence homology classes (SHC) according to the degree of sequence 
identity: acidic keratins (SHC group I); basic keratins (SHC group II); desmin, vimentin and 
other mesenchymal IF proteins, such as glial fibrillary acidic protein (GFAP) (SHC group III); 
neurofilament proteins (SHC group IV); and lamins (SHC group V).
IF building blocks are fibrous proteins stabilized by multistranded left‐handed coiled coils 
giving rise to a rope‐like structure. Their structures are constituted by a long central α‐helical 
region, also designed rod domain, with a distinct number of equally sized coiled coils forming 
segments flanked by non‐α‐helical N‐terminal (the head domain) and C‐terminal domains 
(the tail domain). Both head and tail domains are highly varying in size and sequence, thus, 
the functional and molecular heterogeneity of IF proteins are a consequence of the highly 
variable non‐α‐helical end domains of subunits.
The central rod domain of IF subunits is α‐helical rod highly charged, with a role in the first 
phase of IF assembly. By contrast, the head domain enriched in basic amino acids is essential 
for the formation of tetramers (the polymerization units) and complete IF assembly.
The non‐α‐helical tail domain can vary drastically between different IF proteins. This domain 
is not essential for the assembly of cytoplasmic IFs but plays a significant role in filament 
width control. The functional role of the tail domain is particularly important in the neurofila‐
ments, the neuronal‐specific IFs, as discussed below.
Overall, the assembly of subunits giving rise to functional IFs is a complex and multistep 
process with individual specificities among the different representatives of this molecularly 
heterogeneous family. Taking into account the in vitro polymerization of vimentin, filament 
assembly starts with the formation of parallel, in‐register dimers. These dimers spontane‐
ously associate laterally into antiparallel, half‐staggered tetramers. Tetramers aggregate into 
higher‐order oligomers to form unit length filaments (ULFs) that undergo reorganization and 
elongation by longitudinal annealing to form immature IFs. The final step is radial compac‐
tion of the filaments from approximately16 nm to a diameter of 10–12 nm [3].
Different from the other IFs, NFs comprise three subunits with different molecular masses 
and distributions into the filament. They are formed by light, medium and heavy molecular 
mass NF triplet proteins (NF‐L, NF‐M and NF‐H), respectively. NF‐L can self‐assemble form‐
ing the core of the filament. NF‐M and NF‐H are peripherally disposed on the filament, with 
their long and flexible tails rich in highly charged domains and multiple phosphorylation 
sites, radially projecting out from the filament backbone when NF‐M and NF‐H co‐assemble 
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with the short‐tail NF protein NF‐L. Interestingly, NF‐H and NF‐M by their own are not able 
to assemble into filaments, but by contrast, self‐assembled NF‐L yields normal looking 10‐nm 
filaments. These side arms of NF‐M and NF‐H contain multiple phosphorylation sites regulat‐
ing the interactions of NFs with each other and with other cytoskeletal structures [4].
2.2. Roles of intermediate filaments in neural cell function
Neurons are highly specialized in the transmission and processing of electrical and chemical 
signals. A functional nervous system is dependent of a proper axonal array, which in turn 
is critically dependent upon the organization of the axonal cytoskeleton. Five main subunit 
proteins form the neuronal specific NFs: the group IV NF‐L, NF‐M and NF‐H triplet pro‐
teins, α‐internexin and the group III peripherin. Mature filaments are composed of several 
combinations of these five subunits. In most differentiated neurons, α‐internexin expression 
precedes that of the NF triplet and declines somewhat postnatally, while the expression of 
the NF triplet sharply rises. Neurofilaments found in perikarya, dendrites and axons differ 
considerably in their organization and function. Perikarial NFs form a meshwork around 
the nucleus. In the axons of mature neurons, a large number of longitudinally oriented and 
phosphorylated NFs play a fundamental role increasing the diameter of myelinated axons 
and consequently nerve conductivity. Neurofilaments present in dendrites are less abundant 
and less phosphorylated than those of axons.
Neurofilaments are transported from the cell body, where they are synthesized, to be deliv‐
ered along the axon by a mechanism called axonal transport. The motors implicated in the 
anterograde transport are kinesins, while the retrograde transport is mediated in association 
with dynein, the same motor proteins involved in the fast axonal transport along MTs [4].
The multiple roles of cytoskeletal proteins in the neural cells imply that there is an underlying 
cytoskeletal pathology associated with several neurodegenerative processes. The major neu‐
rodegenerative diseases are characterized by the presence of inclusion bodies in implicated 
neurons. These inclusion bodies all contain elements of the cytoskeleton. In addition, muta‐
tions and/or accumulations of NFs are frequently observed in several human neurodegenera‐
tive disorders including amyotrophic lateral sclerosis, Alzheimer disease, Parkinson disease, 
Charcot‐Marie‐Tooth, giant axonal neuropathy, neuronal intermediate‐filament inclusion 
disease and diabetic neuropathy [5]. Multiple factors can potentially induce the accumulation 
of NF, including deregulation of NF gene expression, NF mutations, defective axonal trans‐
port, abnormal posttranslational modifications and proteolysis [4]. Beyond their association 
with neural damage in inherited or age‐dependent neurodegenerative diseases, studies from 
our laboratory indicated that the disruption of NF homeostasis is a response to toxic agents 
and abnormally accumulated metabolites in rat brain.
Astrocytes are important cytoarchitectural elements of the CNS; however, during the past few 
years, molecular and functional characterization of astroglial cells indicates that they have a 
much broader function than only support the neurons in the brain. Compelling evidence sup‐
ports that astrocytes have specialized functions in inducing and regulating the blood‐brain 
barrier (BBB), glutamate uptake, synaptic transmission, plasticity and metabolic homeosta‐
sis of the brain [6]. Astrocytes express 10 different isoforms of glial fibrillary acidic protein 
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(GFAP), the specific astrocytic IF, together with vimentin, nestin and synemin. However, 
GFAP is the main IF protein expressed in mature astrocytes, where it helps maintaining 
mechanical strength, as well as cell shape. However, recent evidence has shown that GFAP 
plays a role in a variety of additional astrocyte functions, such as cell motility/migration, cell 
proliferation, glutamate homeostasis, neurite outgrowth and injury/protection [7].
Astrocytes are also involved in a wide range of CNS pathologies, including trauma, isch‐
emia and neurodegeneration. In such situations, the cells change both their morphology 
and their expression of many genes leading to activation of astroglia, or astrogliosis. It is 
accepted that the increase of IFs with accompanying cellular hypertrophy and an abnormal 
apparent increase in the number of astrocytes characterize astrogliosis. However, upregula‐
tion of IF proteins, in particular GFAP, but also vimentin and nestin, two IF proteins abun‐
dantly expressed in immature astrocytes, is regarded as the hallmark of astrogliosis [7]. In 
this regard, the most remarkable evidence of the relevance of GFAP in the physiological roles 
of astrocytes in maintaining normal brain function is Alexander disease, a fatal disorder in 
which GFAP mutations might compromise the astrocyte stress response [8].
3. Protein phosphorylation in signaling transduction
Phosphorylation is the most widespread type of posttranslational modification of the intracel‐
lular signaling proteins. Phosphorylation of proteins occurs within seconds or minutes of a 
regulatory signal, typically an extracellular signal.
Phosphorylation is an enzymatic process in which the introduction of a phosphoryl group to 
specific amino acid residues of a protein is catalyzed by protein kinases and the removal of 
phosphoryl groups is catalyzed by protein phosphatases. For phosphorylation to be useful 
in the regulation of a protein activity, it is important to be a reversible process, in which the 
phosphorylated form of the protein could restore its original dephosphorylated form when 
signal ends, functioning therefore as a molecular switch. The addition of a phosphoryl group 
to the side chain of a Ser, Thr, or Tyr residue introduces a bulky, charged group into a polar 
region. The oxygen atoms of a phosphoryl group can hydrogen bond with one or several 
groups in a protein, commonly the amide groups of the peptide backbone at the α‐helix start 
or the charged guanidinium group of an Arg residue influencing the functionality of the 
protein [9].
3.1. Phosphorylation of intermediate‐filament proteins
Phosphorylation, glycosylation and transglutamination take part in the multiple mechanisms 
of IF regulation. However, phosphorylation/dephosphorylation is a major regulatory mecha‐
nism orchestrating IF dynamics. Phosphorylation sites of IF subunits are located on their head 
and tail domains and phosphorylation plays a major role in regulating the structural organi‐
zation and function of these cytoskeletal proteins in a cell‐ and tissue‐specific manner [10].
Amino‐terminal phosphorylation regulates the assembly/disassembly equilibrium of type 
III and IV IFs. Second messenger‐dependent protein kinases add phosphate groups on the 
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amino‐terminal head domain on GFAP, vimentin and NF‐L. Specific phosphorylating sites 
for cAMP‐dependent protein kinase (PKA), Ca2+/calmodulin‐dependent protein kinase II 
(PKCaMII) and protein kinase C (PKC) are associated with IF disassembly; however, the 
action of the protein phosphatases 1, 2A and 2B (PP1, PP2A and PP2B), respectively, removes 
phosphate and restores the IF ability to polymerize [11].
Otherwise, the main phosphorylation sites on NF‐M and NF‐H are located in Lys‐Ser‐Pro 
(KSP) repeat regions of the tail domain of these subunits. The KSP repeats are phosphor‐
ylated by proline‐directed kinases such as Cdk5, the mitogen‐activated protein kinases 
(MAPK) such as Erk1/2, JNK, p38MAPK as well as glycogen synthase kinase 3 (GSK3). 
Phosphorylation of these KSP sites regulates the interactions of NFs with each other and 
with other cytoskeletal structures, since the tail domain of NF‐M and NF‐H protrudes later‐
ally from the filament backbone to form “side‐arms” when phosphorylated. These lateral 
interactions are central in the formation of a cytoskeletal lattice that supports the mature 
axon. Moreover, carboxyl‐terminal phosphorylation of NF‐M and NF‐H subunits has long 
been considered to regulate their axonal transport rate and in doing so to provide stability 
to mature axons [12]. The axonal transport of NFs results from binding to the fast motor 
proteins kinesin and dynein intermitted with prolonged pauses. It is known that carboxyl‐
terminal phosphorylation of NF‐H progressively restricts the association of NFs with kinesin 
and stimulates its interaction with dynein. This event could represent one of the mechanisms 
by which aberrant carboxyl‐terminal phosphorylation would slow NF axonal transport. Both 
the maintenance of axonal caliber and axonal transport are dependent on the adequately 
phosphorylated NF subunits. Consequently, abnormally hyperphosphorylated NF subunits, 
commonly found in several neurodegenerative diseases, are intimately associated with neu‐
ral dysfunction and considered a hallmark of neurodegeneration. In addition, demyelinating 
diseases might be associated with hypophosphorylated NFs, compromised axonal transport 
and decreased axonal diameter, since the phosphorylation of NFs occurs in close proximity 
to myelin sheaths, which release signals needed to induce phosphorylation of NFs in mature 
axons [13].
In the next sections, we discuss the recent findings from our laboratory indicating that sig‐
naling mechanisms involved in the regulation of IF phosphorylation/dephosphorylation are 
important targets of neurotoxins, metabolites accumulating in neurodegenerative diseases as 
well as thyroid hormones, emphasizing the relevance of cytoskeletal homeostasis on the brain 
function/dysfunction. To assess the effects of the neurotoxicants on the phosphorylation level 
of IF proteins, we developed an approach to measure the in vitro incorporation of radioactive 
phosphate (32P‐orthophosphate) into these proteins [14]. In order to shed light onto the sig‐
naling cascades targeted by them, we used pharmacological and immunological approaches, 
specific enzyme inhibitors, channel blockers, or glutamate antagonists as well as monoclonal 
antibodies directed to signaling cascades or specific phosphorylation sites. We conclude that 
misregulated cell signal transduction interferes with the phosphorylation/dephosphorylation 
of IFs disrupting the homeostasis of the cytoskeleton of astrocytes and neurons and this is 
associated with cell dysfunction and neurodegeneration in experimental models of neurotox‐
icity. Figure 2 corresponds to a schematic representation of the consequences of misregulated 
NF phosphorylation for neuronal function.
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3.2. Central roles of Ca2+ and glutamate receptors on the regulation of cytoskeletal 
dynamics in neural cells
Changes in the cytoplasmic free Ca2+ concentration constitute one of the main pathways by 
which information is transferred from extracellular signals received by animal cells to intra‐
cellular sites. However, an augmented Ca2+ influx through the NMDA receptor or voltage‐
dependent calcium channels (VDCCs) can be responsible for the activation of lethal metabolic 
pathways in neural cells. Overactivation of glutamate receptors produces neuronal membrane 
depolarization. This causes the influx of Ca2+ into the cytoplasm and subsequently triggers cas‐
cade events leading to excitotoxic neuronal death. Excitotoxicity is recognized as a major patho‐
logical process of neuronal death in neurodegenerative diseases involving the CNS. In this 
regard, compelling findings point to the cytoskeleton as an end point of excitotoxic mechanisms.
Different toxins and stress conditions are implicated in the misregulation of intracellular 
Ca2+‐dependent processes in cells and different cell types exhibit a diverse range of transient 
responses to their stimuli. Exposure of tissue slices to neurotoxicants or metabolites in toxic 
concentrations triggers the activation of ionotropic and metabotropic glutamate receptors 
as well as L‐VDCC and the endoplasmic reticulum (ER) Ca2+ channels. These receptors and 
channels activate several intracellular‐signaling complexes altering cell behavior in a spatio‐
temporally regulated manner. Metabolism of cyclic nucleotides, membrane phospholipids 
as well as endogenous enzymatic regulators are the key biochemical steps coordinating cell 
response to an extracellular stimulus [15].
Calcium is a critical regulator of cytoskeletal dynamics. Dysregulation of Ca2+ homeosta‐
sis is an important event in driving the disruption of assembly/disassembly equilibrium as 
Figure 2. Schematic representation of disrupted neurofilament phosphorylation. The hyperphosphorylation of neurofil‐ 
aments can change the cytoskeleton architecture and lead to neurofilament aggregation in perikarya and in axon accounting 
for cell damage.
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well as the interaction of cytoskeletal proteins with regulatory proteins or cell organelles. 
In particular, IF proteins are directly regulated by Ca2+ levels, which crosslink signaling cas‐
cades and connect physiological or pathological extracellular signals with the IF cytoskeleton 
influencing multiple aspects of cell behavior. Consequently, abnormally elicited Ca2+ signals 
provoking misregulation of key phosphorylation cascades are able to disrupt cytoskeletal 
homeostasis and this is commonly associated with the cell damage.
4. Toxicity of diphenyl ditelluride on the cytoskeleton of neural cells
Many processes in the organic synthesis, vulcanization of rubber and in metal‐oxidizing solu‐
tions to tarnish metals, such as silver, extensively use tellurium. Diphenyl ditelluride (PhTe)
2
 
is the simplest of the aromatic, diorganoyl ditelluride compounds used in organic synthesis. 
Indeed, developmental exposure to (PhTe)
2
 is teratogenic and is associated with long‐term 
behavioral and neurochemical changes in rats. Until recently, the general toxicity of (PhTe)
2
 
was considered to be exclusively related to the oxidation of thiol‐containing proteins (for 
review, see [16]). However, compelling evidence from our laboratory points to an important 
role played by signaling mechanisms involved in regulating IF phosphorylation/dephosphor‐
ylation as target of (PhTe)
2
 neurotoxicity. In addition, we evidence a remarkable role of Ca2+ 
mediating these actions secondary to glutamate receptors and L‐VDCC activation.
The neurotoxicity of (PhTe)
2
 is spatiotemporally regulated, consistent with the window of sus‐
ceptibility of signaling cascades as well as the structural and functional heterogeneity of neu‐
rons in different brain regions. In this regard, exposure of cortical slices from 18‐ and 21‐day‐old 
rats to (PhTe)
2
 shows unaltered phosphorylation of IF proteins, while IFs of acute cortical slices 
from younger pups (9 and 15 days old) are hypophosphorylated. Activated ionotropic gluta‐
mate receptors, L‐VDCC and ryanodine channels result in PP1‐mediated hypophosphoryla‐
tion of GFAP and NF subunits pointing to the cortical cytoskeleton as a preferential target of 
the action of phosphatases in this window of vulnerability. Activation of PP1 is modulated by 
dopamine and cyclic AMP‐regulated neuronal phosphoprotein 32 (DARPP‐32), an important 
endogenous Ca2+‐mediated inhibitor of PP1 activity. Depending on the site of phosphorylation, 
DARPP‐32 is able to produce opposing biochemical effects, that is, inhibition of PP1 activity or 
inhibition of protein kinase A (PKA) activity [17]. Decreased cAMP and PKA catalytic subunits 
support that (PhTe)
2
 disrupts the cytoskeletal‐associated phosphorylating/dephosphorylating 
system of neurons and astrocytes through PKA‐mediated inactivation of DARPP‐32, promot‐
ing PP1 release and hypophosphorylation of IF proteins of those neural cells [18]. Regarding 
neurons, hypophosphorylation of IF proteins could be associated with cell dysfunction since 
decreased phosphorylation of KSP repeats in the carboxyl‐terminal domains of NF‐M and 
NF‐H correlates with impaired axonal transport and increased NF‐packing density.
In contrast with younger rats, hippocampal slices of 21‐day‐old rats acutely exposed to 
(PhTe)
2
 result in hyperphosphorylated IFs. Hippocampal IF hyperphosphorylation is par‐
tially dependent on L‐VDCC, NMDA and ER Ca2+ channels. The signal evoked by (PhTe)
2
 is 
also transduced through metabotropic glutamate receptors on the plasma membrane, leading 
to the activation of phospholipase C (PLC) that produces the intracellular messengers inositol 
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1,4,5‐trisphosphate (IP3) and diacylglycerol (DAG). IP3 binds to specific receptors on the ER 
changing the conformation of IP3 receptors and opening the channel. Released Ca2+ and DAG 
directly activate PKCaMII and PCK, resulting in the hyperphosphorylation of some of the 
critical amino acid residues in the carboxyl‐terminal tail domain of NF‐L known to interfere 
with filament assembly. In addition, the activation of Erk1/2 and p38MAPK results in hyper‐
phosphorylation of KSP repeats of NFM. Interestingly, PKCaMII and PKC are upstream of 
MAPK activation implying in a significant cross‐talk among signaling pathways elicited by 
(PhTe)
2
 that connect the glutamate metabotropic cascade with the activation of Ca2+ channels. 
The final molecular result is the extensive phosphorylation of amino‐ and carboxyl‐terminal 
sites on IF proteins and deregulated cytoskeletal homeostasis [19].
4.1. Diphenyl ditelluride disrupts the cytoskeleton and provokes neurodegeneration  
in acutely injected young rats
The in vivo exposure to (PhTe)
2
, in which the neurotoxicant reaches the brain via systemic 
circulation, also results in different susceptibilities of the IF proteins from neural cells. This 
can be evidenced in cerebral cortex and hippocampus of 15‐day‐old rats acutely injected with 
a toxic dose of (PhTe)
2
 (0.3 µmol/kg body weight) [20]. Cortical hyperphosphorylation of neu‐
ronal and glial IF proteins is an early and persistent event up to 6 days after injection, accom‐
panied by increased levels of GFAP and NF‐L. Upregulated gene expression as well as GFAP 
and vimentin hyperphosphorylation could be a response to injury and take part in the pro‐
gram of reactive astrogliosis, as further demonstrated in striatum [21] and cerebellum [22] of 
(PhTe)
2
‐injected rats. In addition, hippocampal IFs are not responsive to the insult until wean‐
ing. A strong evidence supports an important role of astrocytes in a more severe cortical than 
hippocampal damage following the in vivo (PhTe)
2
 insult. This supports a direct action of the 
neurotoxicant on intracellular signaling pathways and highlights the relevance of the inter‐
play between glial and neuronal cells to adapt the cellular metabolic response to the insult 
even when the brain connections are only partially preserved, as shown in acute brain slices.
Of importance, neurodegeneration is part of the deleterious in vivo effects of (PhTe)
2
 tox‐
icity, as demonstrated in the striatum [23] and cerebellum [22] of (PhTe)
2
‐injected rats. 
Neurodegeneration is associated with alterations in Ca2+ homeostasis and glutamatergic 
neurotransmission, upstream of inhibited Akt and activated caspase 3. We therefore propose 
that excitotoxicity is a main mechanism of neurodegeneration caused by this compound in 
the developing rat brain. On the other hand, most of the actions of (PhTe)
2
 disrupting the 
homeostasis of the cytoskeleton in neural cells are mediated by high Ca2+ levels. Moreover, 
a link among disrupted IF homeostasis, activated astrocytes and neuronal apoptosis in 
(PhTe)
2
‐injected rats has been demonstrated by immunohistochemical approaches. In addi‐
tion, MAPK pathway might be a link between altered IF equilibrium and neural cell damage, 
since MAPK is implicated in IF hyperphosphorylation and neurodegeneration as well in the 
brain structures attained by (PhTe)
2
 toxicity. Further supporting the cytoskeleton as an end 
point of neurotoxicity, hyperphosphorylated NFs can inhibit their proteolytic breakdown by 
calpain, a Ca2+‐activated protease. In addition, abnormally phosphorylated NFs accumulate 
in the perikarya and the phospho‐NF aggregates can thus become cytotoxic by the enduring 
impairment of axonal transport of NFs (see Figure 2). The increased time the NF spent in the 
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cell body is thought to result in further aberrant phosphorylation and may prevent them from 
entering the axon, resulting in a deleterious feedback loop [24].
In summary, we propose that complex and integrated actions mediate the (PhTe)
2
 toxicity 
directed to the cytoskeleton of neural cells. These molecular mechanisms induce spatiotem‐
poral responses of the cells because of the different windows of susceptibility of the develop‐
mental brain. Nonetheless, the Ca2+ ‐initiated events highlight a role for this neurotoxicant as 
a disruptor of the cytoskeleton.
5. Cytoskeleton as a target of amino acids and their metabolites
Misregulated cytoskeletal homeostasis is among the molecular mechanisms underlying the 
neural cell dysfunction in brain tissue exposed to high levels of amino acids and/or their 
metabolites. In humans, several neurological impairments are associated with enzymatic 
deficiencies or defects in proteins involved in cellular metabolism of neural cells, causing 
accumulation of metabolic intermediates associated with neuronal damage. We discuss some 
aspects of the molecular mechanisms underlying the disruption of cytoskeletal homeosta‐
sis in response to branched‐chain keto acids (BCKAs) derived from leucine, isoleucine and 
valine. We also addressed the effects of homocysteine and quinolinic acid (QUIN), a metabo‐
lite of tryptophan metabolism, directed to the cytoskeleton.
5.1. Branched chain α‐keto acids and the cytoskeleton of neural cells
The branched‐chain ketoacids, α‐ketoisocaproic acid (KIC), α‐keto‐β‐methylvaleric acid 
(KMV) and α‐keto‐isovaleric acid (KIV) are produced from the respective branched‐chain 
amino acids (BCAAs) leucine, isoleucine and valine, in the reaction catalyzed by the branched‐
chain α‐keto acid dehydrogenase (BCKAD) complex. A deficiency of the BCKAD complex is 
an inherited metabolic disease known as maple syrup urine disease (MSUD) which lead to the 
accumulation of BCAAS and BCKAs in tissues and body fluids resulting in dramatic cerebral 
symptoms [25].
Curiously, cortical slices of young rats exposed to high levels of the BCAAs individually pre‐
serve the homeostasis of the cytoskeleton. On the other hand, their respective keto acids pro‐
vide an interesting example of the fine‐tune regulation of the cytoskeleton, since KIC [26] and 
KMV [27] were differently deleterious to the homeostasis of the cytoskeleton. KIC and KMV 
alter the dynamics of IF proteins of astrocytes and neurons through different transduction 
mechanisms dependent on excessive intracellular Ca2+ influx, while KIV appears not to be 
involved in the disruption of the IF cytoskeleton [28].
The effect of KIC is outlined by hypophosphorylation of GFAP, NF‐M and NF‐L in very young 
rats (up to 12 days of age) changing to hyperphosphorylation of the same proteins later in 
development (17 days of age). Nonetheless, both responses of the cytoskeletal‐associated 
phosphorylating system are regulated by Ca2+ currents through the NMDA and L‐VDCC, as 
well as by the intracellular Ca2+storage release from the ER, leading to a differential  activation 
of protein phosphatases or kinases [28]. These paradoxical findings provide an interesting 
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insight into the differential susceptibility of cortical IF cytoskeleton to the exposure to 
pathological levels of this metabolite. The different vulnerabilities of the cytoskeleton of 
cortical cells during development might be ascribed to the temporal maturation mediated 
by a multitude of developmental processes and signaling pathways. It is conceivable that 
they are associated with the pathological role of the developmentally regulated glutamate 
receptors in neural cells since the expression patterns of glutamate receptor subunit genes 
change during the ontogeny of the brain. Distinct regional and temporal patterns of the 
expression of types and subtypes of the glutamate ionotropic receptors during ontogeny 
may possibly explain the different signaling pathways targeting the cytoskeleton of corti‐
cal neural cells during development.
Interestingly, KMV disturbs the IF‐associated cytoskeletal phosphorylation only in 12‐day‐old 
rats without changing the phosphorylation level of these proteins in younger or older animals, 
showing a specific window of vulnerability of cytoskeleton to KMV insult in the cerebral cor‐
tex of developing brain. Strikingly, this effect was dependent on intracellular Ca2+ concentra‐
tions; however, in this case ɣ‐amino butyric acid A and B (GABA
A
 and GABAB, respectively) rather than glutamate receptors were involved in this action. This is in agreement with GABA
A
 
and GABAB receptors mediating the induction and maintenance of Ca2+ levels [27].
Overall, we propose that BCKAs in supra‐physiological concentrations disrupt the cytoskeleton 
of rat brain through misregulation of the phosphorylating system associated with the IF cyto‐
skeleton. We evidenced developmentally regulated mechanisms in which Ca2+‐mediated excito‐
toxicity plays a critical role in destabilizing the cytoskeleton that may ultimately disrupt normal 
cell function and viability. Although evidence from animal models should be taken with cau‐
tion, we can propose that the disrupted cytoskeleton is part of the physiopathology of MSUD.
5.2. Hyperhomocysteinemia and the cytoskeleton of neural cells
Homocysteine (Hcy) is a sulfur‐containing amino acid generated during methionine metabolism. 
Genetic mutations impairing Hcy metabolism cause accumulation of this amino acid attaining 
high levels in blood, leading to severe hyperhomocysteinemia and brain damage. Otherwise, 
along with genetic factors, mild‐moderate hyperhomocysteinemia is associated with nutritional 
imbalance and hormonal factors. Mild hyperhomocysteinemia, which markedly enhance the 
vulnerability of neuronal cells to excitotoxicity and oxidative imbalance, is also common in older 
people, constituting an independent risk factor for stroke and cognitive impairment [29].
Various existing experimental evidences from our group link hyperhomocysteinemia and cyto‐
skeletal misregulation, supporting that disrupted cytoskeleton could be an end point of neural 
dysfunction in this neurometabolic disorder. Experiments with brain slices acutely exposed to 
mild Hcy levels (100 µM) showed greater vulnerability of hippocampal cytoskeleton as com‐
pared with cortical one. Moreover, a window of vulnerability of the cytoskeleton of hippocam‐
pal cells is evidenced, since misregulated phosphorylation is detected only at postnatal day 
17 [30], reflecting an altered activity of the endogenous phosphorylating system associated 
with the IFs in this brain structure. As expected, NMDA receptors, L‐VDCC and extracellular 
Ca2+influx result in PKC and PKCaMII activation. The prevention of Hcy action through the 
inhibition of PKC and MEK, a step that is upstream of MAPK cascade (Raf‐1/MEK/MAPK), 
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is consistent with an effect at the level of the monomeric GTPase Raf‐1, supporting a role for 
PKC phosphorylating and activating Raf‐1 in the Hcy‐induced modulation of the cytoskeleton.
In contrast with hypophosphorylation found in hippocampal slices, the chemically induced 
chronic hyperhomocysteinemia differently alters the signaling mechanisms directed to the 
cytoskeleton, producing PP1‐, PP2A‐ and PP2B‐mediated hypophosphorylation of NF sub‐
units and GFAP in hippocampal slices of 17‐day‐old rats without affecting the cerebral cortex 
[31] through glutamate and Ca2+‐mediated mechanisms. Further evidence that homocysteine 
targets the cytoskeleton came from cytoskeletal reorganization in primary astrocytes and neu‐
rons exposed to homocysteine [32]. Dramatically altered actin cytoskeleton in primary astro‐
cytes exposed to 100 µM Hcy is consistent with the role of actin as a main determinant of cell 
morphology. Concomitant disrupted GFAP meshwork underlies the remodeled actin cyto‐
skeleton and altered cell morphology. These findings provide further evidence of the cross‐talk 
among the different cytoskeletal subsystems and the roles played by the toxic levels of Hcy.
Therefore, taking into account our experimental evidence it is conceivable that disturbed cell 
signaling is an important determinant of the disrupted homeostasis of the cytoskeleton as a 
whole, with widespread consequences on cell function that could be associated with human 
hyperhomocysteinemia.
6. Cytoskeleton is a target of quinolinic acid neurotoxicity
Quinolinic acid is a neuroactive metabolite of the kynurenine pathway normally found in 
nanomolar concentrations in human brain and cerebrospinal fluid (CSF). QUIN is antagonist 
of NMDA receptor and it has a high in vivo potency as an excitotoxin supporting involvement 
in the pathogenesis of a variety of human neurological diseases. The neurotoxicity of QUIN 
results from complex mechanisms including presynaptic receptors, energetic dysfunction, 
oxidative stress, transcription factors and behavior [33]. We experimentally demonstrate that 
the disruption of the cytoskeleton, in particular, misregulation of the phosphorylation system 
associated with the IFs, is a target of QUIN toxicity in injected rat striatum, tissue slices and 
primary astrocytes and neurons in culture.
6.1. Effects of intrastriatally injected quinolinic acid on the cytoskeleton of neural cells
Acute intrastriatal injection of QUIN (150 nmol/0.5 µL) in adolescent rats (30 days old) pro‐
vokes NF‐L and GFAP hyperphosphorylation 30 min after infusion, evidencing the suscepti‐
bility of the cytoskeleton of both neurons and astrocytes in the early events of QUIN toxicity. 
Hyperphosphorylated NF‐LSer55 destabilizes the NF structure and this might represent an 
early step in the pathophysiological cascade of deleterious events exerted by QA in rat striatum. 
Experimental insights to get light on the molecular mechanisms underlying this effect point to 
NMDA‐mediated Ca2+ events and oxidative stress upstream of activated second messenger‐
dependent protein kinases PKA, PKC and PKCaMII, but not MAPKs after QUIN infusion [34].
A link between misregulation of cell‐signaling mechanisms, disruption of IF phosphory‐
lation and cell damage as part of QUIN toxicity becomes more evident analyzing the 
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long‐lasting effect of the acute intrastriatal injection of QUIN in adolescent rats on the dynam‐
ics of the phosphorylating system until 21 days after injection [35]. The acutely injected QUIN 
alters the homeostasis of IF phosphorylation in a selective manner, progressing from stria‐
tum to cerebral cortex and hippocampus. Twenty‐four hours after QUIN injection, the IFs are 
hyperphosphorylated in the striatum. This effect progresses to cerebral cortex causing hypo‐
phosphorylation at day 14 and appears in the hippocampus as hyperphosphorylation at day 
21 after QUIN infusion, PKA and PKCaMII mediating this effect. However, MAPKs (Erk1/2, 
JNK and p38MAPK) are hyperphosphorylated/activated only in the hippocampus, suggest‐
ing different signaling mechanisms in these two brain structures during the first weeks after 
QUIN infusion. Also, PP1 and PP2B‐mediated hypophosphorylation of the IF proteins in the 
cerebral cortex 14 days after QUIN injection reinforces the selective signaling mechanisms in 
different brain structures. Increased GFAP immunocontent in the striatum and cerebral cortex 
24 h and 14 days after QUIN injection, respectively, suggests reactive astrocytes in these brain 
regions. Yet, we observe biochemical and histopathological alterations in the striatum, cortex 
and hippocampus, as well as altered behavioral tests in response to the long‐lasting exposure 
to QUIN through glutamate and Ca2+‐mediated mechanisms. Thus, it is tempting to propose 
that the long‐lasting deleterious effect of intrastriatal QUIN injection could be due to the fact 
that QUIN interferes with the highly regulated signaling mechanisms targeting the cytoskel‐
eton in the immature brain [36].
6.2. Insight into the molecular basis of quinolinic acid action toward the cytoskeleton
Studies in acute brain slices further support the role of glutamatergic signaling and Ca2+ over‐
load disturbing the cytoskeletal equilibrium downstream of QUIN exposure. Moreover, this 
experimental approach brings light on the cell‐specific mechanisms targeting the cytoskeleton 
in astrocytes and neurons when the cell connections are partially preserved. In astrocytes, 
the QUIN action is mainly due to increased Ca2+ influx through NMDA and L‐VDCC. In 
neuronal cells, QUIN acts through the activation of metabotropic glutamate receptors and 
influx of Ca2+ through NMDA receptors and L‐VDCC, as well as Ca2+ release from intracellu‐
lar stores. These mechanisms then set off a cascade of events including the activation of PKA, 
PKCaMII and PKC, which phosphorylate head domain sites on GFAP and NFL. Moreover, 
Cdk5 is activated downstream of mGluR5, phosphorylating the KSP repeats on NFM and 
NFH. Metabotropic glutamate receptors type 1 (mGluR1) is upstream of PLC, which, in turn, 
produce DAG and IP3 promoting hyperphosphorylation of KSP repeats on the tail domain of 
NFM and NFH [37].
6.3. The cytoskeleton of astrocytes and neurons responds differently to quinolinic  
acid toxicity
The susceptibility of the cytoskeleton to toxic levels of QUIN is also detectable in isolated astro‐
cytes and neurons growth in primary cultures [38]. In astrocytes, Ca2+‐mediated glutamate mech‐
anisms target the endogenous phosphorylating system, since metabotropic glutamate receptors 
and Ca2+ influx through NMDA receptors are upstream of PKA, PKCaMII and PKC activa‐
tion, provoking GFAP hyperphosphorylation. Interestingly, the misregulated  phosphorylation 
system leads to a reversible and dramatically altered actin cytoskeleton with concomitant change 
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of morphology to fusiform and/or flattened cells with retracted cytoplasm and  disruption of the 
GFAP meshwork [39] supporting the dynamic behavior of the cytoskeleton.
Interestingly, neurons show greater vulnerability to QUIN than astrocytes (10×). Neurons 
exposed to QUIN presented PKA‐ and PKC‐mediated hyperphosphorylation of NF subunits. 
These effects are also downstream of ionotropic and metabotropic glutamate signaling and 
Ca2+ influx through NMDA receptors and L‐VDCC. The misregulated signaling pathways dis‐
rupt the neuronal cytoskeleton, evaluated by altered neurite/neuron ratios and neurite out‐
growth. It is important to consider that microtubules play a central role in cell polarity [40]. 
In particular, microtubules are the main determinants of neuronal polarity and regulation of 
microtubule dynamics includes tubulin posttranslational modifications [40] and phosphoryla‐
tion of microtubule‐associated proteins (MAPs), whose binding to microtubules is essential 
for neurite formation [41]. As an example, activated GSK‐3β leads to increased phosphoryla‐
tion of some MAPs, destabilizing microtubules with consequence for neurite stabilization [42]. 
Therefore, the neurite destabilization could derive from both NFs and microtubules disruption.
Interestingly, we found a protective role of astrocyte‐conditioned medium on the disrupted 
neuronal cytoskeleton and morphometric alterations, suggesting that QUIN‐induced trophic 
factors secreted by astrocytes are able to modulate signaling mechanisms targeting the neu‐
ronal cytoskeleton. More interestingly, co‐cultured astrocytes and neurons preserve their 
cytoskeletal organization and cell morphology together with unaltered activity of the phos‐
phorylating system associated with the cytoskeleton. In other words, co‐cultured astrocytes 
and neurons tightly and actively interact with one another reciprocally protecting themselves 
against QUIN injury [38]. This evidence raise the question about the role played by the acti‐
vated microglia eliciting signals essential to destabilize the astrocytic and neuronal cytoskel‐
eton but this hypothesis remains to be clarified.
All together, we conclude that among the multiple mechanisms through which accumulated 
QUIN is able to induce cell damage, our experimental evidence points to Ca2+‐mediated 
mechanisms directed to the cytoskeletal disruption as an end point of QUIN toxicity. Both in 
vivo and ex vivo approaches clearly demonstrate a wide spectrum of misregulated signaling 
mechanisms downstream of QUIN action directly affecting the cytoskeleton and disrupting 
cell homeostasis. We also provide evidence that impaired physiological equilibrium of the 
signaling cascades directed to the cytoskeleton underlies QUIN cytotoxicity and is associated 
with neurodegeneration. The in vitro results showing disorganized cytoskeleton and altered 
cell morphology further support the cytoskeleton as a hallmark of stress condition that could 
be implicated in the human brain disorders associated with high QUIN levels.
7. Cytoskeleton of neural cells is a target of thyroid hormones
Thyroid hormones are essential for the development and function of central nervous sys‐
tem. In brain, these hormones are essential for myelination [43, 44], neuritogenesis [45], 
synaptic plasticity [46–48], IF phosphorylation [49–54], cell differentiation and maturation 
[55]. Considering the role of these hormones on brain development, thyroid diseases might 
account for brain injury as well as alteration in mood and cognition [56].
Cytoskeleton - Structure, Dynamics, Function and Disease246
The classical mechanism of thyroid hormone action involves the modulation of nuclear 
receptors by 3,5,3′‐triiodo‐l‐thyronine (T
3
). The nuclear receptors are ligand‐dependent tran‐
scription factors, which are involved in the genomic‐dependent effects of thyroid hormones. 
However, there are numerous physiological effects of these hormones that cannot be medi‐
ated by the genome‐like mechanism, due the short time frame in which the response occurs. 
Nongenomic actions of thyroid hormones are defined as events that (i) do not primarily 
involve the cell nucleus, (ii) are rapid in onset (minutes or a few hours) relative to transcrip‐
tion and translation and (iii) do not require gene transcription and protein synthesis [57]). 
These events are triggered by rapid/nongenomic responses that are frequently associated 
with secondary messenger‐signaling pathways.
7.1. Insight into the molecular basis of genomic and nongenomic action of thyroid 
hormones toward the cytoskeleton of neural cells
The first evidence of nongenomic actions of thyroid hormones targeting the cytoskeleton 
demonstrated the thyroxine‐dependent modulation of actin polymerization in cultured astro‐
cytes. Thyroxine (T
4
) was involved in the conversion of soluble actin to a fibrous form through 
nongenomic mechanism [58].
While many of the T
3
 actions are mediated by genomic‐dependent mechanisms, T
4
 and reverse 
3,3′,5′‐triiodothyronine (reverse T
3
, rT
3
) exert direct, The nongenomic effects in neural cells. 
Both T
4
 and rT
3
 hormones control actin polymerization in cultured astrocytes without affect‐
ing gene expression. The authors suggested that these events might contribute to thyroid 
hormone's influence on brain development. Subsequently, the same research group showed 
that both T
4
 and rT
3
, but not T
3
, directly regulate the F‐actin content of elongating neurites of 
cerebellar neurons. These results provide a molecular mechanism for the influence of thyroid 
hormones on brain development that is independent of regulated gene expression [59].
Trentin and Moura Neto [60] demonstrated that T
3
 altered the organization of GFAP in cer‐
ebellar astrocytes in culture. GFAP filaments that normally spread in the cytoplasm of astro‐
cytes became organized around the cell nucleus. In addition, Zamoner and coworkers [51] 
showed that both T
3
 and T
4
 induced GFAP phosphorylation and reorganization in glioma 
C6 cells through the inhibition of RhoA GTPase. The modulation of GFAP was accompanied 
by increased proliferation of glioma cells. Taking together, these results suggest that thyroid 
hormones may be important regulators of astrocyte growth and differentiation.
Despite the evidence that nongenomic actions of thyroid hormones initiated at the plasma 
membrane via integrin αVβ3 [57, 61], the complexity of the processes underlying the differen‐
tial mechanisms of action to thyroid hormones suggests the existence of multiple binding sites 
for these hormones. In this context, it has been previously demonstrated that both T
3
 and T
4
 
may modulate the GABAergic system and induce PKA‐ and PKCaMII‐mediated hyperphos‐
phorylation of vimentin, GFAP, NF‐M and NF‐L in cerebral cortex from very young rats (up 
to 10 days of age) [50]. However, only T
4
 caused hyperphosphorylation of the same proteins 
later in development (15 days of age) through GABA‐independent mechanisms [49]. These 
paradoxical findings provide an interesting insight into the differential susceptibility of corti‐
cal IF cytoskeleton to thyroid hormone exposure.
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Calcium‐dependent mechanisms play a central role on the thyroid hormone‐induced modula‐
tion of the phosphorylating system associated with IFs. Zamoner and colleagues [49] demon‐
strated that the nongenomic mechanisms underlying the effects T
4
 targeting the IF‐associated 
phosphorylating system in cerebral cortex from 15‐day‐old rats are dependent on extracel‐
lular Ca2+ influx through VDCC, as well as Ca2+ release from ER stores.
Taking into account that in rat the myelination peak is coincident with postnatal day 15 and 
that this is a period of intense synaptogenesis, the NF hyperphosphorylation induced by T
4
 in 
cerebral cortex from 15‐day‐old rats appears to be correlated to synaptogenesis and myelination 
(for review, see [53]).
In summary, we could suggest that nongenomic actions of T
4
 targeting the cytoskeleton of 
glial cells and neurons might account for neuronal cell migration, myelination, synaptogen‐
esis and synaptic plasticity. Moreover, the modulation of NF phosphorylation by thyroid hor‐
mone may control axonal caliber.
7.2. Hypothyroidism and the cytoskeleton of neural cell
The effects of thyroid hormones in central nervous system during development include the 
modulation of the cytoskeleton dynamics. Hypothyroidism in the developing rat brain is asso‐
ciated with oxidative stress and aberrant intraneuronal accumulation of NFs in the perikaryon 
of Purkinje neurons (see Figure 2). The authors suggested that the neuron alterations observed 
in the developing hypothyroid brain are comparable to those seen in neurodegenerative dis‐
eases [62]. Corroborating these findings, it has been shown that the effects of hypothyroidism 
on neuronal cytoskeleton involve the developmental modulation of specific isoforms of protein 
expression, which induce stoichiometric imbalance between the NF triplet [52]. In addition, 
thyroid hormone deficiency induces a delay and a partial arrest of astrocyte differentiation, 
supported by the decreased expression of GFAP both in cortical [52] and in hippocampal astro‐
cytes [54], which was accompanied by downregulation of the astrocyte glutamate transport‐
ers. These findings are associated with the extracellular signal‐regulated kinase (ERK)1/2 and 
c‐jun terminal kinase (JNK) activation. NF hyperphosphorylation might account for the aber‐
rant intraneuronal accumulation of these cytoskeletal structures previously described [62].
Our research group demonstrated the hyperphosphorylation of tail KSP repeats on NF‐H in 
hypothyroid cortical and hippocampal neurons [52, 54]. The carboxyl‐terminal phosphoryla‐
tion of NF‐H progressively restricts association of NFs with kinesin, the axonal anterograde 
motor protein and stimulates its interaction with dynein, the axonal retrograde motor protein 
[63]. This event could represent one of the mechanisms by which carboxyl‐terminal phos‐
phorylation would slow NF axonal transport.
Taking into account our experimental evidence, we propose that the consequences of congeni‐
tal hypothyroidism to neural cells involve IF hyperphosphorylation, misregulation of gluta‐
mate‐glutamine cycle, oxidative stress and glutamate excitotoxicity. These events suggest a 
compromised astroglial defense system that is probably playing a role in the physiopathology 
of the neurological dysfunction of hypothyroidism (Figure 3).
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Figure 3. Role of glutamate excitotoxicity on intermediate‐filament dynamics and cell damage. Congenital hypothyroid‐ 
ism leads to glutamate excitotoxicity, calcium overload, and oxidative stress. These events are related to intermediate‐
filament (GFAP and NF) hyperphosphorylation and neural cell damage.
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8. General conclusion
Studies of our group on the endogenous phosphorylating system associated with the IF pro‐
teins of neural cells point to a critical role of disrupted cytoskeleton in response to a variety 
of signals both in physiological and in pathological conditions. Our findings highlight the 
IFs as a preferential target of the signal transduction pathways. Importantly, a large body of 
evidence shows a link among misregulation of cell‐signaling mechanisms, disruption of IF 
phosphorylation and cell damage in response to different stress signals. While the exact sig‐
naling pathways regulating NF phosphorylation remains elusive, there is increasing evidence 
that known signal transduction cascades are involved. These actions can be initiated by the 
activation of NMDA‐, L‐VDCC, or G protein‐coupled receptors and the signal is transduced 
downstream of Ca2+ mobilization or monomeric GTPase activation through different kinase/
phosphatase pathways, regulating the dynamics of the cytoskeleton. Figure 4 summarizes 
Figure 4. Summary of calcium‐associated mechanisms triggered by thyroid hormones, quinolinic acid, diphenyl 
ditelluride, branched‐chain keto acids, and homocysteine targeting intermediate‐filament phosphorylation in neural 
cells. Calcium influx through the NMDA receptor or voltage‐dependent calcium channels (VDCC) can be responsible for 
the activation of lethal metabolic pathways in neural cells. Augmented intracellular Ca2+ levels might be associated with 
the modulation of diverse cell‐signaling pathways and exhibit a diverse range of responses to their stimuli.
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the calcium‐associated mechanisms triggered by thyroid hormones, quinolinic acid, (PhTe)
2
, 
BCKAs and homocysteine targeting IF phosphorylation in neural cells.
Despite the focus on the misregulation of IF dynamics in response to signaling mechanisms 
downstream of metabolites and neurotoxicants, we should consider that cytoskeleton is a 
complex meshwork of interconnecting filaments [1]. In this regard, the morphological altera‐
tions demonstrated in primary cells in culture mainly reflect the reorganization of the mesh‐
work of filaments. Taking into account our findings, we propose that misregulation of kinase/
phosphatase cascades downstream of stressors could disrupt the cytoskeleton as a whole and 
this might be an important determinant of neural dysfunction associated with the action of 
neurotoxicants and in neurometabolic conditions.
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